Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies










Image Number 6 for United States Patent #7611708.

Methods of therapy for B-cell malignancies are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity when the antibody binds a CD40 antigen on a normal human B cell, exhibits antagonist activity when the antibody binds a CD40 antigen on a malignant human B cell, and can exhibit antagonist activity when the antibody binds a CD40 antigen on a normal human B cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of malignant human B cells.








 
 
  Recently Added Patents
Antimicrobial flush solutions
Stable light source device
Query processing with specialized query operators
Defensin polynucleotides and methods of use
Constant low-flow air source control system and method
Electrical installation arrangement
Accelerator for a read-channel design and simulation tool
  Randomly Featured Patents
Electric strike assembly
Belt driving device having a belt shift correcting member
Vertical closure hinge with an anti-binding feature
Foil backed laminate reinforcement
Multi-functional body armor
Beach erosion control device
Bushing for a jet engine vane
Ciclosporin form for pulmonary administration
Method and apparatus for automatically sampling pulses a predetermined average number of times for storage and subsequent reproduction
13-transmembrane protein expressed in prostate cancer